Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
33.53B | 30.47B | 27.45B | 27.39B | 25.41B | 32.91B | Gross Profit |
4.80B | 5.01B | 2.55B | 1.39B | 381.00M | 6.78B | EBIT |
-1.54B | -1.09B | -3.21B | -4.52B | -6.06B | -309.00M | EBITDA |
2.79B | 3.62B | 3.89B | 1.78B | 398.00M | 4.35B | Net Income Common Stockholders |
274.00M | 656.00M | 943.00M | -1.05B | -3.29B | 629.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.50B | 3.97B | 4.45B | 5.29B | 5.29B | 4.54B | Total Assets |
95.10B | 98.40B | 94.11B | 92.50B | 92.12B | 89.83B | Total Debt |
27.36B | 25.72B | 27.69B | 26.69B | 21.90B | 20.76B | Net Debt |
23.87B | 21.75B | 23.24B | 21.41B | 16.61B | 16.75B | Total Liabilities |
53.74B | 56.79B | 54.89B | 53.81B | 52.74B | 47.55B | Stockholders Equity |
40.35B | 40.65B | 38.36B | 37.81B | 38.39B | 41.13B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.12B | -4.58B | -5.01B | -2.66B | -2.78B | Operating Cash Flow |
0.00 | 5.53B | 449.00M | -1.12B | 2.89B | 2.50B | Investing Cash Flow |
0.00 | -3.65B | -2.15B | -3.56B | -2.94B | -2.87B | Financing Cash Flow |
0.00 | -2.36B | 894.00M | 4.66B | 1.25B | 69.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥13.34B | 7.68 | 0.30% | 2.97% | -16.90% | ||
70 Neutral | ¥44.28B | 14.61 | 1.76% | -1.86% | -2.54% | ||
66 Neutral | ¥245.08B | 10.89 | 1.85% | 7.94% | -5.97% | ||
66 Neutral | $4.48B | 12.24 | 5.32% | 248.54% | 4.09% | -12.10% | |
65 Neutral | ¥44.24B | 8.70 | 2.50% | 0.92% | 55.82% | ||
64 Neutral | ¥18.25B | 13.24 | 1.33% | 10.64% | 110.18% | ||
54 Neutral | ¥18.14B | 15.73 | 0.89% | -0.82% | 12.58% |